IDH (Isocitrate DeHydrogenase) mutational status also impacts GAM subpopulation prevalence, resulting in a higher proportion of Mo-GAMs in more aggressive IDH wild-type gliomas (14, 16, 21). This evidence concerns the gene IDH1 and central nervous system cancer.